Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-09-06
1989-07-11
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3141
Patent
active
048472760
ABSTRACT:
This invention relates to a novel method for the treatment of hemorrhagic and thrombotic thrombocytosis by means of administration of a 5-(4-chlorophenyl)-2,4-dimethyl-3H-1,2,4-triazole-3-thione.
REFERENCES:
patent: 4775688 (1988-10-01), Kane et al.
Chemical Abstracts 107: 154339g (1987).
J. M. Kane: Synthesis(10), 912-14 (1987).
J. M. Kane, M. W. Dudley, S. M. Sorenson, and F. P. Miller: J. Med. Chem. 31(6), 1253-8 (1988).
Goldberg Jerome D.
Merrell Dow Pharmaceuticals Inc.
Simmons Edlyn S.
LandOfFree
Treatment of thromobocytosis with 5-(4-chlorophenyl)-2,4-diemthy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of thromobocytosis with 5-(4-chlorophenyl)-2,4-diemthy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of thromobocytosis with 5-(4-chlorophenyl)-2,4-diemthy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-437514